Cargando…

sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients

BACKGROUND: Measurement of prostate-specific antigen (PSA) advanced the diagnostic and prognostic potential for prostate cancer (PCa). However, due to PSA’s lack of specificity, novel biomarkers are needed to improve risk assessment and ensure optimal personalized therapy. A set of protein molecules...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsaur, Igor, Thurn, Kristina, Juengel, Eva, Gust, Kilian M., Borgmann, Hendrik, Mager, Rene, Bartsch, Georg, Oppermann, Elsie, Ackermann, Hanns, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490684/ https://www.ncbi.nlm.nih.gov/pubmed/25967040 http://dx.doi.org/10.1186/s13046-015-0161-6

Ejemplares similares

Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients
por: Tsaur, Igor, et al.
Publicado: (2016)

Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells
por: Tsaur, Igor, et al.
Publicado: (2015)

CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study
por: Tsaur, Igor, et al.
Publicado: (2015)

I Publish in I Edit? - Do Editorial Board Members of Urologic Journals Preferentially Publish Their Own Scientific Work?
por: Mani, Jens, et al.
Publicado: (2013)

Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo
por: Juengel, Eva, et al.
Publicado: (2013)

Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib
por: Juengel, Eva, et al.
Publicado: (2015)

Use of complementary and alternative medicine before and after organ removal due to urologic cancer
por: Mani, Jens, et al.
Publicado: (2015)

Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells
por: Makarević, Jasmina, et al.
Publicado: (2014)

Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2
por: Makarević, Jasmina, et al.
Publicado: (2014)

Publication of Original Research in Urologic Journals – A Neglected Orphan?
por: Mani, Jens, et al.
Publicado: (2012)

Deciphering the Molecular Machinery—Influence of sE-Cadherin on Tumorigenic Traits of Prostate Cancer Cells
por: Tsaur, Igor, et al.
Publicado: (2021)

Feasibility, complications and oncologic results of a limited inguinal lymph node dissection in the management of penile cancer
por: Tsaur, Igor, et al.
Publicado: (2015)

What should be the patient’s preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospital
por: Mani, Jens, et al.
Publicado: (2016)

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned
por: Thomas, Christian, et al.
Publicado: (2016)

Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors
por: Jennewein, Lukas, et al.
Publicado: (2018)

HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A
por: Juengel, Eva, et al.
Publicado: (2014)

Amygdalin Influences Bladder Cancer Cell Adhesion and Invasion In Vitro
por: Makarević, Jasmina, et al.
Publicado: (2014)

HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells
por: Juengel, Eva, et al.
Publicado: (2017)

Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro
por: Juengel, Eva, et al.
Publicado: (2019)

Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In Vitro
por: Tsaur, Igor, et al.
Publicado: (2022)

Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis
por: Wedel, Steffen, et al.
Publicado: (2011)

Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells
por: Vallo, Stefan, et al.
Publicado: (2017)

Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells
por: Tsaur, I, et al.
Publicado: (2012)

Sulforaphane inhibits proliferation and invasive activity of everolimus-resistant kidney cancer cells in vitro
por: Juengel, Eva, et al.
Publicado: (2016)

Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic Oncology
por: Borgmann, Hendrik, et al.
Publicado: (2021)

Detection of early DJ-stent encrustation by sonographic twinkling-artifacts – a pilot study
por: Blaheta, Roman A., et al.
Publicado: (2017)

Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion
por: Juengel, Eva, et al.
Publicado: (2016)

Correction: Renal cell carcinoma alters endothelial receptor expression responsible for leukocyte adhesion
por: Juengel, Eva, et al.
Publicado: (2017)

Plant-Derived Sulforaphane Suppresses Growth and Proliferation of Drug-Sensitive and Drug-Resistant Bladder Cancer Cell Lines In Vitro
por: Xie, Hui, et al.
Publicado: (2022)

Utilization of surgical safety checklists by urological surgeons in Germany: a nationwide prospective survey
por: Borgmann, Hendrik, et al.
Publicado: (2015)

Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway
por: Markowitsch, Sascha D., et al.
Publicado: (2022)

Understanding tumor localization in multiparametric MRI of the prostate—effectiveness of 3D printed models
por: Haack, Maximilian, et al.
Publicado: (2023)

Impact of primary resistance to front-line targeted therapy in metastatic renal cell carcinoma on subsequent immune-checkpoint-inhibition
por: Börner, J. H., et al.
Publicado: (2023)

Robotic surgery can be safely performed for patients and healthcare workers during COVID‐19 pandemic
por: Sparwasser, Peter, et al.
Publicado: (2021)

Mistletoe Extracts from Different Host Trees Disparately Inhibit Bladder Cancer Cell Growth and Proliferation
por: Juengel, Eva, et al.
Publicado: (2023)

Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic
por: Dotzauer, Robert, et al.
Publicado: (2020)

Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway
por: Rutz, Jochen, et al.
Publicado: (2022)

Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
por: Thomas, Anita, et al.
Publicado: (2021)

The feasibility of ureteral tissue engineering using autologous veins: an orthotopic animal model with long term results
por: Engel, Oliver, et al.
Publicado: (2014)

Integrin α2 and β1 Cross-Communication with mTOR/AKT and the CDK-Cyclin Axis in Hepatocellular Carcinoma Cells
por: Juratli, Mazen A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9nu1cttvpra0r9v7lhchameqi7